finasteride has been researched along with Breast Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badrinarayan, P; Ganesher, A; Gupta, P; Konwar, R; Panda, G; Rai, S; Sastry, GN; Singh, J; Singh, R | 1 |
| Bergfeld, W; Murad, A | 1 |
| Freites-Martinez, A; Geer, EB; Goldfarb, S; Lacouture, ME; Rozner, RN; Shapiro, J | 1 |
| Elizalde, PV; Mercogliano, MF; Rivas, MA; Schillaci, R; Wiebe, JP | 1 |
| Lehrer, S | 1 |
| Dunn, BK; Greenwald, P; Umar, A | 1 |
| Ellis, RJ; Lee, SC | 1 |
| Zielinski, SL | 1 |
| Hampton, T | 1 |
| Dunn, BK; Ford, LG | 1 |
| Brawley, OW; Ford, LG; Johnson, KA; Kramer, BS; Nayfield, SG; Perlman, JA | 1 |
| Henderson, BE; Pike, MC; Ross, RK | 1 |
| Brawley, OW; Cheson, BD; Phillips, PH | 1 |
5 review(s) available for finasteride and Breast Neoplasms
| Article | Year |
|---|---|
5-alpha-reductase inhibitor treatment for frontal fibrosing alopecia: an evidence-based treatment update.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Breast Neoplasms; Depression; Dutasteride; Evidence-Based Medicine; Female; Fibrosis; Finasteride; Forehead; Hair; Humans; Scalp; Sexual Dysfunction, Physiological | 2018 |
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Finasteride; Hormone Antagonists; Humans; Spironolactone | 2019 |
Future directions in cancer prevention.
Topics: Aromatase Inhibitors; Azasteroids; Breast Neoplasms; Cancer Vaccines; Diet; Dutasteride; Female; Finasteride; Humans; Immunotherapy; Life Style; Male; Motor Activity; Neoplasms; Nicotiana; Obesity; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Vaccines | 2012 |
Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.
Topics: Androgen Receptor Antagonists; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Finasteride; Humans; Male; Primary Prevention; Prostatic Neoplasms; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen | 2007 |
The potential for hormonal prevention trials.
Topics: 5-alpha Reductase Inhibitors; Adult; Breast Neoplasms; Female; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Receptors, Estrogen; Tamoxifen | 1994 |
8 other study(ies) available for finasteride and Breast Neoplasms
| Article | Year |
|---|---|
Targeting progesterone metabolism in breast cancer with l-proline derived new 14-azasteroids.
Topics: Antineoplastic Agents; Azasteroids; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; MCF-7 Cells; Models, Molecular; Molecular Structure; Progesterone; Proline; Structure-Activity Relationship | 2017 |
Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride.
Topics: 5-alpha Reductase Inhibitors; 5-alpha-Dihydroprogesterone; Animals; Breast; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cholestenone 5 alpha-Reductase; Female; Finasteride; Humans; Mice; Mice, Inbred BALB C; Progesterone | 2015 |
Finasteride for postmenopausal breast cancer prevention.
Topics: 5-alpha Reductase Inhibitors; Breast Neoplasms; Female; Finasteride; Humans; Postmenopause; Prognosis | 2015 |
Prevention of prostate cancer with finasteride.
Topics: 5-alpha Reductase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Finasteride; Gynecomastia; Humans; Male; Prostatic Neoplasms | 2003 |
Despite positive studies, popularity of chemoprevention drugs increasing slowly.
Topics: Adenomatous Polyposis Coli; Androgen Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Celecoxib; Cell Transformation, Neoplastic; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Prescriptions; Female; Finasteride; Humans; Male; Neoplasms; Prostatic Neoplasms; Pyrazoles; Sulfonamides; Tamoxifen; United States | 2004 |
Clinical trials point to complexities of chemoprevention for cancer.
Topics: Aspirin; Breast Neoplasms; Clinical Trials as Topic; Diet; Dihydrotestosterone; Female; Finasteride; Humans; Male; Neoplasms; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Tamoxifen; Vitamin E | 2005 |
Hormonal chemoprevention of cancer in women.
Topics: 5-alpha Reductase Inhibitors; Adult; Age Factors; Aged; Androstenes; Anticarcinogenic Agents; Azasteroids; Breast Neoplasms; Contraceptives, Oral; Endometrial Neoplasms; Estrogen Replacement Therapy; Female; Finasteride; Humans; Incidence; Male; Middle Aged; Ovarian Neoplasms; Progestins; Prostatic Neoplasms; Tamoxifen; United Kingdom; United States | 1993 |
Clinical trials referral resource. Breast cancer and prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Adult; Anticarcinogenic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Finasteride; Humans; Male; Prostatic Neoplasms; Tamoxifen | 1996 |